Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0465839B2 - - Google Patents
[go: Go Back, main page]

JPH0465839B2 - - Google Patents

Info

Publication number
JPH0465839B2
JPH0465839B2 JP19709883A JP19709883A JPH0465839B2 JP H0465839 B2 JPH0465839 B2 JP H0465839B2 JP 19709883 A JP19709883 A JP 19709883A JP 19709883 A JP19709883 A JP 19709883A JP H0465839 B2 JPH0465839 B2 JP H0465839B2
Authority
JP
Japan
Prior art keywords
solvent
drying
nucleotide reagent
nucleotide
valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP19709883A
Other languages
Japanese (ja)
Other versions
JPS6089493A (en
Inventor
Yoshiaki Oosugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Priority to JP19709883A priority Critical patent/JPS6089493A/en
Publication of JPS6089493A publication Critical patent/JPS6089493A/en
Publication of JPH0465839B2 publication Critical patent/JPH0465839B2/ja
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】 (イ) 産業上の利用分野 この発明は、DNAやRNAを合成するDNA等
合成装置に関する。
[Detailed Description of the Invention] (a) Industrial Application Field The present invention relates to a DNA synthesis device for synthesizing DNA and RNA.

(ロ) 従来技術 DNA等の合成では水分もしくは湿気の存在を
さけることが必要な工程が含まれており、このた
め例えば特開昭58−148897号や特開昭58−148898
号に開示のようにDNA等合成装置に乾燥工程を
もたせることが提案されている。
(B) Prior art The synthesis of DNA, etc. includes a step that requires avoiding the presence of water or moisture, and for this reason, for example, Japanese Patent Application Laid-Open No. 58-148897 and Japanese Patent Application Laid-open No. 58-148898
It has been proposed that a DNA synthesis device be equipped with a drying process, as disclosed in the issue.

しかし従来提案されている乾燥工程は、DNA
合成開始から完了までのDNA合成の稼動中を考
慮したもので、DNA合成完了から次のDNA合成
開始までのDNA合成の停止中を考慮したもので
はない。
However, the conventionally proposed drying process
This takes into consideration the period during which DNA synthesis is in operation from the start of synthesis to its completion, and does not take into consideration the period during which DNA synthesis is stopped, from the completion of DNA synthesis to the start of the next DNA synthesis.

ところが、DNA等合成装置では、DNA合成完
了後もヌクレオチド試薬用容器などに液体が残つ
ており、その液体が水分もしくは湿気を吸収保持
するので、次のDNA合成開始のときに問題とな
る場合がある。
However, in DNA synthesis equipment, even after DNA synthesis is complete, liquid remains in the nucleotide reagent container, etc., and this liquid absorbs and retains moisture, which may cause problems when starting the next DNA synthesis. be.

(ハ) 発明の目的 この発明は、DNA合成の停止中を考慮した乾
燥工程を実施する機能をもつたDNA等合成装置
を提供する。
(c) Purpose of the Invention The present invention provides a DNA synthesis apparatus having a function of performing a drying process while taking into account the suspension of DNA synthesis.

(ニ) 発明の構成 この発明のDNA等合成装置は、多数のヌクレ
オチド試薬用容器から各々のヌクレオチド試薬溶
液が所定の手順で反応器に自動供給されてDNA
等の合成を行う装置において、多数のヌクレオチ
ド試薬用容器の任意の1つにその容器を洗浄・乾
燥するための溶媒を供給する手段およびその溶媒
を排出しかつ乾燥機能を与える乾燥ガスの供給手
段を付設し、また前記2つの供給手段を順に他の
ヌクレオチド試薬用容器に対応させる切換手段を
設け、さらに前記2つの供給手段および前記切換
手段を所望時間をおいて作動制御しうる作動制御
手段を付設しこの作動制御手段の作動によつて自
動的に合成反応修了後の各ヌクレオチド試薬用容
器を溶媒、次いで乾燥ガスによつて洗浄・乾燥可
能としたことを特徴とするものである。
(d) Structure of the Invention The apparatus for synthesizing DNA, etc. of the present invention automatically supplies each nucleotide reagent solution from a large number of nucleotide reagent containers to a reactor according to a predetermined procedure.
In an apparatus for synthesizing nucleotide reagents, a means for supplying a solvent for washing and drying the container to any one of a large number of nucleotide reagent containers, and a means for supplying a drying gas for discharging the solvent and providing a drying function. and a switching means for making the two supply means correspond to other nucleotide reagent containers in sequence, further comprising an operation control means capable of controlling the operation of the two supply means and the switching means at a desired time interval. The apparatus is characterized in that each nucleotide reagent container after the completion of the synthesis reaction can be automatically washed and dried with a solvent and then with a drying gas by the operation of the attached operation control means.

(ホ) 実施例 第1図に示す1は、この発明の一実施例であ
り、ホスホトリエステル法によるDNA自動合成
装置である。
(e) Example 1 shown in FIG. 1 is an example of the present invention, which is an automatic DNA synthesis apparatus using the phosphotriester method.

2〜6はそれぞれタンクに貯溜されている試薬
もしくは溶媒で、2は無水酢酸とピリジンの混合
液からなるマスキング用試薬、3はジメチルアミ
ノピリジンとピリジンの混合液からなるマスキン
グ用縮合剤、4はピリジンからなる反応用溶媒、
5はトリクロロ酢酸と塩化メチレンの混合液から
なる保護基脱離用試薬、6は塩化メチレンからな
る洗浄・乾燥用溶媒である。
2 to 6 are reagents or solvents stored in tanks, respectively. 2 is a masking reagent consisting of a mixture of acetic anhydride and pyridine, 3 is a masking condensing agent consisting of a mixture of dimethylaminopyridine and pyridine, and 4 is a masking reagent consisting of a mixture of dimethylaminopyridine and pyridine. A reaction solvent consisting of pyridine,
5 is a protecting group removal reagent consisting of a mixed solution of trichloroacetic acid and methylene chloride, and 6 is a washing/drying solvent consisting of methylene chloride.

7は6方ロータリーバルブからなるソルベント
バルブで、そのポート7a〜7fのいずれか一つ
のポート7gに連通させるものである。
A solvent valve 7 is a six-way rotary valve, and is connected to any one of the ports 7a to 7f, 7g.

8は流路内の液の有無を検知する液センサであ
る。
8 is a liquid sensor that detects the presence or absence of liquid in the flow path.

9〜13はそれぞれ3方電磁弁である。 9 to 13 are three-way solenoid valves, respectively.

14は2流路の10方ロータリーバルブからなる
リージエントバルブで、そのポート14aと14
A,14bと14B……,14jと14Jのいず
れかのポート対の一つをポート対14kと14K
にそれぞれ連通させるものである。なお、第1図
では図面の都合上、ポート14e〜14Jは省略
されている。
14 is a reient valve consisting of a 10-way rotary valve with two flow paths, and its ports 14a and 14
A, 14b and 14B..., 14j and 14J, one of the port pairs 14k and 14K
The two are connected to each other. Note that in FIG. 1, ports 14e to 14J are omitted for convenience of drawing.

16〜19は、ヌクレオチド試薬調製容器であ
る。リージエントバルブ14の図示省略のポート
14e〜14Jに対応したヌクレオチド試薬調整
容器20〜25もあるが、それらは第1図では図
面の都合上、図示省略されている。
16 to 19 are nucleotide reagent preparation containers. There are also nucleotide reagent adjustment containers 20 to 25 corresponding to ports 14e to 14J (not shown) of the reagent valve 14, but they are not shown in FIG. 1 for the sake of simplification.

26は反応器である。27,28はそれぞれ2
方電磁弁である。
26 is a reactor. 27 and 28 are 2 each
It is a solenoid valve.

29は上記バルブ等をコントロールする制御回
路、30はその制御回路29の操作卓である。
Reference numeral 29 is a control circuit for controlling the above-mentioned valves, etc., and 30 is an operation console for the control circuit 29.

DNAの合成に際しては、第2図に示すように、
まずヌクレオチド試薬調整容器16に2種類の粉
体試薬A,Bをフイルタ16a,16bで支持し
て収容する。下段の粉体試薬Aは結晶状態の縮合
剤〔2−4−6−トリメチルベンゼンスルホニル
−3−ニトロトリアゾリド(MSNT)〕であり、
上段の粉体試薬Bは結晶状態のヌクレオチド試薬
である。
When synthesizing DNA, as shown in Figure 2,
First, two types of powder reagents A and B are contained in the nucleotide reagent preparation container 16, supported by filters 16a and 16b. Powder reagent A in the lower row is a crystalline condensing agent [2-4-6-trimethylbenzenesulfonyl-3-nitrotriazolide (MSNT)],
Powder reagent B in the upper row is a nucleotide reagent in a crystalline state.

他のヌクレオチド試薬調整容器17〜25にも
同様に縮合剤とヌクレオチド試薬を収容してお
く。
Condensing agents and nucleotide reagents are similarly stored in other nucleotide reagent preparation containers 17 to 25.

次に反応器26にDNA分子の末端部分のみを
結合した支持体を入れ、操作卓30を介してスタ
ート指令を与える。
Next, a support to which only the terminal portion of the DNA molecule is bound is placed in the reactor 26, and a start command is given via the operator console 30.

これにより制御回路29は、ソルベントバルブ
7でポート7fと7gを連通し、3方電磁弁9,
12,13を第1図実線の流路位置にしかつ1
0,11を破線の流路位置にし、2方電磁弁2
7,28を閉じるから、窒素ガス圧により洗浄・
乾燥用溶媒6が反応器26に供給され貯溜され
る。所定時間後、3方電磁弁9を破線の流路位置
にして溶媒6を止めると共に、2方電磁弁27を
開けて3方電磁弁9から反応器26までの流路に
入つている溶媒6をすべて反応器26に送り込
み、2方電磁弁27を閉じる。そのまゝしばらく
置いた後、3方電磁弁13を破線の流路位置と
し、かつ方電磁弁28を開けて、反応器26内の
溶媒6を窒素ガス圧で排出する。以上により支持
体が予備洗浄される。
As a result, the control circuit 29 connects the ports 7f and 7g with the solvent valve 7, and the three-way solenoid valve 9,
12 and 13 in the flow path position shown by the solid line in Figure 1, and 1
0 and 11 are in the flow path position indicated by the broken line, and the two-way solenoid valve 2
Since 7 and 28 are closed, the nitrogen gas pressure is used to clean and
A drying solvent 6 is supplied to the reactor 26 and stored therein. After a predetermined period of time, the three-way solenoid valve 9 is moved to the flow path position indicated by the broken line to stop the solvent 6, and the two-way solenoid valve 27 is opened to remove the solvent 6 that has entered the flow path from the three-way solenoid valve 9 to the reactor 26. are all fed into the reactor 26, and the two-way solenoid valve 27 is closed. After leaving it as it is for a while, the three-way solenoid valve 13 is set to the flow path position indicated by the broken line, the one-way solenoid valve 28 is opened, and the solvent 6 in the reactor 26 is discharged under nitrogen gas pressure. As described above, the support is preliminarily washed.

予備洗浄において溶媒6を反応器26から排出
する間に、ソルベントバルブ7でポート7aと7
gを連通し、3方電磁弁9を実線の流路位置にし
かつ12を破線の流路位置とすることによつて、
ソルベントバルブ7から3方電磁弁9までの流路
に残つていた溶媒6を排出してしまう。
While draining the solvent 6 from the reactor 26 in the pre-wash, the solvent valve 7 connects ports 7a and 7.
g is communicated, the three-way solenoid valve 9 is placed in the flow path position indicated by the solid line, and the 3-way solenoid valve 12 is placed in the flow path position indicated by the broken line.
The solvent 6 remaining in the flow path from the solvent valve 7 to the three-way solenoid valve 9 will be discharged.

予備洗浄の後、同様のバルブ等の操作によつ
て、反応器26にマスキング用試薬2を供給し、
またマスキング用縮合剤3を供給する。これによ
り支持体およびそれに結合しているDNA分子の
末端部分の反応基が保護基でブロツクされる。す
なわちマスキングされる。
After preliminary cleaning, the masking reagent 2 is supplied to the reactor 26 by operating the same valves, etc.
Also, a masking condensing agent 3 is supplied. This blocks the reactive groups at the ends of the support and the DNA molecules bound thereto with protecting groups. In other words, it is masked.

マスキングの後、反応器26に洗浄・乾燥用溶
媒6を供給し、洗浄を行う。
After masking, a cleaning/drying solvent 6 is supplied to the reactor 26 to perform cleaning.

次に、反応器26に保護基脱離用試薬5を供給
すると、支持体に結合されているDNA分子の末
端部分の所定部位の反応基をブロツクしていた保
護基が脱離され、反応可能となる。
Next, when the protecting group removal reagent 5 is supplied to the reactor 26, the protecting group blocking the reactive group at a predetermined site on the end portion of the DNA molecule bonded to the support is removed, making it possible to react. becomes.

保護基脱離の後、洗浄・乾燥用溶媒6を反応器
26に供給して洗浄し、次いで窒素ガスを流路お
よび反応器26に所定時間通じる。以上により反
応器26等が洗浄・乾燥される。
After removal of the protecting group, a washing/drying solvent 6 is supplied to the reactor 26 for washing, and then nitrogen gas is passed through the flow path and the reactor 26 for a predetermined period of time. As described above, the reactor 26 and the like are cleaned and dried.

洗浄・乾燥の後、ソルベントバルブ7でポート
7dと7gを連通し、3方電磁弁9〜13を実線
の流路位置とし、リージエントバルブ14でポー
ト14aと14k,14Aと14Kをそれぞれ連
通すると、反応用溶媒4がヌクレオチド試薬調整
容器16を流通するが、そのときヌクレオチド試
薬Aおよび縮合剤Bは溶解され試薬溶液となつて
反応器26に供給される。所定時間後、3方電磁
弁9を破線の流路位置にして反応用溶媒4を止
め、かつ2方電磁弁27を開けて3方電磁弁9か
ら反応器26までの流路に入つている反応用溶媒
4をすべて反応器26に送り込み、2方電磁弁2
7を閉じる。
After washing and drying, ports 7d and 7g are communicated with solvent valve 7, three-way solenoid valves 9 to 13 are placed in the flow path position shown by the solid line, and ports 14a and 14k, 14A and 14K are communicated with regent valve 14, respectively. The reaction solvent 4 flows through the nucleotide reagent preparation container 16, and at this time, the nucleotide reagent A and the condensing agent B are dissolved and supplied to the reactor 26 as a reagent solution. After a predetermined period of time, the three-way solenoid valve 9 is moved to the flow path position indicated by the broken line to stop the reaction solvent 4, and the two-way solenoid valve 27 is opened to enter the flow path from the three-way solenoid valve 9 to the reactor 26. All of the reaction solvent 4 is sent to the reactor 26, and the two-way solenoid valve 2
Close 7.

反応器26では、時間の経過と共に縮合反応が
すゝみ、支持体に結合されたDNA分子を末端部
分の所定部位に新たなヌクレオチドが連結され
る。
In the reactor 26, the condensation reaction progresses over time, and a new nucleotide is linked to a predetermined site at the end of the DNA molecule bound to the support.

所定の縮合反応時間の後、3方電磁弁9を実線
の流路位置にしかつ2方電磁弁28を開にして反
応用溶媒4を流通して流路および反応器26を洗
浄する。
After a predetermined condensation reaction time, the three-way solenoid valve 9 is placed in the flow path position indicated by the solid line, and the two-way solenoid valve 28 is opened to allow the reaction solvent 4 to flow through and clean the flow path and the reactor 26.

この後、前記マスキングの処理に戻り、以下の
一連の処理を繰り返す。ただし、ヌクレオチド試
薬調整容器は17〜25までを順次使用してい
く。
Thereafter, the process returns to the masking process and repeats the following series of processes. However, nucleotide reagent preparation containers 17 to 25 are used in sequence.

これによつて、ヌクレオチド試薬調整容器16
〜25に入れたヌクレオチド試薬の塩基シーケン
スと同じ塩基配列をもつDNAが合成される。
As a result, the nucleotide reagent adjustment container 16
DNA having the same base sequence as that of the nucleotide reagent placed in ~25 is synthesized.

さて制御回路29は、最終の縮合反応が終了
し、その後の反応用溶媒4での洗浄も終ると、ソ
ルベントバルブ7でポート7fと7gを連通し、
3方電磁弁9〜13を実線の流路位置とし、リー
ジエントバルブ14でポート14aと14k,1
4Aと14Kをそれぞれ連通し、さらに2方電磁
弁28を開にする。これにより洗浄・乾燥用溶媒
6がヌクレオチド試薬調整容器16は流通し、洗
浄する。しばらくの洗浄の後、リージエントバル
ブ14でポート14bと14k,14Bと14K
をそれぞれ連通すれば、次のヌクレオチド試薬調
整容器17が洗浄される。以下同様に洗浄・乾燥
用溶媒6を流したまゝリージエントバルブ14を
切り換えて全てのヌクレオチド試薬調整容器を順
に洗浄する。
Now, when the final condensation reaction is completed and the subsequent washing with the reaction solvent 4 is completed, the control circuit 29 connects the ports 7f and 7g with the solvent valve 7,
The three-way solenoid valves 9 to 13 are placed in the flow path position shown by the solid line, and the regent valve 14 is connected to ports 14a, 14k, and
4A and 14K are connected to each other, and the two-way solenoid valve 28 is opened. As a result, the washing/drying solvent 6 flows through the nucleotide reagent preparation container 16 and is washed. After cleaning for a while, connect ports 14b and 14k, 14B and 14K with regent valve 14.
When these nucleotide reagent preparation containers 17 are communicated with each other, the next nucleotide reagent preparation container 17 is washed. Thereafter, all the nucleotide reagent preparation containers are sequentially washed by switching the reagent valve 14 while the washing/drying solvent 6 is kept flowing in the same manner.

ヌクレオチド試薬調整容器16〜25の洗浄の
後、3方電磁弁10,11を破線の流路位置と
し、両電磁弁10,11間の流路を洗浄する。
After cleaning the nucleotide reagent adjustment containers 16 to 25, the three-way solenoid valves 10 and 11 are placed in the flow path position indicated by the broken line, and the flow path between the two solenoid valves 10 and 11 is cleaned.

次いで、ソルベントバルブ7でポート7aと7
gを連通し、窒素ガスを流通することにより溶媒
流路を乾燥する。さらにその後、3方電磁弁1
0,11を実線の流路位置とし、リージエントバ
ルブ14を切り換えることによつて窒素ガスを流
通し、順次すべてのヌクレオチド試薬調整容器1
6〜25を乾燥する。
Next, the solvent valve 7 connects ports 7a and 7.
The solvent channel is dried by communicating with g and flowing nitrogen gas. Furthermore, after that, 3-way solenoid valve 1
0 and 11 are the flow path positions indicated by the solid line, and by switching the reagent valve 14, nitrogen gas is passed through all the nucleotide reagent adjustment containers 1 in sequence.
Dry 6-25.

以上の洗浄・乾燥が終了した後、装置1は停止
するが、最後の洗浄・乾燥によつてヌクレオチド
試薬調整容器16〜25には液体が一切残されて
いないから、装置1の長時間停止していても液体
が水分を吸収保持することがなく、次の装置1の
運転は好適に行われうることとなる。
After the above washing and drying is completed, the apparatus 1 is stopped, but since there is no liquid left in the nucleotide reagent preparation containers 16 to 25 due to the final washing and drying, the apparatus 1 is stopped for a long time. The liquid will not absorb or retain moisture even if the liquid is in the water, and the next operation of the apparatus 1 can be carried out suitably.

次に他の実施例を説明する。装置構成として
は、制御回路29の作動が異なるだけで第1図に
示す装置1と基本的には同じである。最後の縮合
反応が終了し、その後の反応用溶媒4での洗浄も
終ると、制御回路29がオペレータに信号を発し
て待機状態となる。そこでオペレータがマスキン
グ用試薬2、マスキング用縮合剤3、反応用溶媒
4および保護基脱離用試薬5をすべて洗浄・乾燥
用溶媒に入れ替えて再び操作卓30から指示を与
えると、制御回路29は、ソルベントバルブ7で
ポート7bと7gを連通してそこから洗浄・乾燥
用溶媒を流路に流通し、洗浄・乾燥用溶媒が無く
なつたことを液センサ8が確認したら、その後し
ばらく窒素ガスを流しつづけて乾燥を行い、これ
をソルベントバルブ7の各ポート7c〜7eにつ
いて同様に繰返し行い、最後のポート7fについ
ては前記装置1と同様にヌクレオチド試薬調整容
器16〜25の洗浄・乾燥も含めて洗浄・乾燥を
行う。
Next, another embodiment will be described. The device configuration is basically the same as the device 1 shown in FIG. 1, except that the operation of the control circuit 29 is different. When the last condensation reaction is completed and the subsequent washing with the reaction solvent 4 is also completed, the control circuit 29 issues a signal to the operator and enters a standby state. Therefore, when the operator replaces all of the masking reagent 2, masking condensing agent 3, reaction solvent 4, and protecting group removal reagent 5 with washing/drying solvents and gives instructions again from the console 30, the control circuit 29 , ports 7b and 7g are communicated with the solvent valve 7, and the cleaning/drying solvent is passed through the channel from there. When the liquid sensor 8 confirms that the cleaning/drying solvent is used up, nitrogen gas is supplied for a while. Drying is carried out by continuous flow, and this is repeated in the same manner for each port 7c to 7e of the solvent valve 7, and for the last port 7f, cleaning and drying of the nucleotide reagent adjustment containers 16 to 25 are also carried out in the same manner as in the device 1. Wash and dry.

この実施例の装置では、装置全体の流路に液体
が一切残されないから、装置の停止期間における
水分吸収による悪影響を殆んど完全になくすこと
が可能となる。
In the apparatus of this embodiment, since no liquid remains in the flow paths of the entire apparatus, it is possible to almost completely eliminate the adverse effects of moisture absorption during the period when the apparatus is stopped.

洗浄・乾燥用溶媒の他の具体例としては、ジオ
キサン、テトラヒドロフラン(THF)、アセトン
などの揮発性溶媒を挙げることができる。
Other specific examples of cleaning and drying solvents include volatile solvents such as dioxane, tetrahydrofuran (THF), and acetone.

乾燥ガスの他の具体例としては、アルゴンガス
を挙げることができる。
Other specific examples of drying gas include argon gas.

(ヘ) 発明の効果 この発明のDNA等合成装置によれば、装置の
停止時には少なくともヌクレオチド試薬用容器が
完全乾燥されて液体が一切残されないから、液体
が水分を吸収保持することにより次の装置の作動
時に悪影響を与えることが防止され、長期の装置
停止の後でも好適にDNA等の合成を行いうるよ
うになる。
(F) Effects of the Invention According to the DNA synthesis apparatus of the present invention, at least the nucleotide reagent container is completely dried when the apparatus is stopped, and no liquid remains. This prevents any adverse effects during the operation of the system, and enables the synthesis of DNA, etc., even after a long period of equipment shutdown.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図はこの発明のDNA等合成装置の一実施
例の構成説明図、第2図は第1図に示す装置のヌ
クレオチド試薬調整容器の一つの断面図である。 1……DNA等自動合成装置、6……洗浄・乾
燥用溶媒、7……ソルベントバルブ、14……リ
ージエントバルブ、16〜19……ヌクレオチド
試薬調整容器、26……反応器。
FIG. 1 is an explanatory diagram of the configuration of one embodiment of the apparatus for synthesizing DNA, etc. of the present invention, and FIG. 2 is a sectional view of one of the nucleotide reagent preparation containers of the apparatus shown in FIG. 1. DESCRIPTION OF SYMBOLS 1...Automatic synthesizer for DNA etc., 6...Washing/drying solvent, 7...Solvent valve, 14...Regient valve, 16-19...nucleotide reagent adjustment container, 26...Reactor.

Claims (1)

【特許請求の範囲】 1 多数のヌクレオチド試薬用容器から各々のヌ
クレオチド試薬溶液が所定の手順で反応器に自動
供給されてDNA等の合成を行う装置において、 多数のヌクレオチド試薬用容器の任意の一つに
その容器を洗浄・乾燥するための溶媒を供給する
手段およびその溶媒を排出しかつ乾燥機能を与え
る乾燥ガスの供給手段を付設し、また前記2つの
供給手段を順に他のヌクレオチド試薬用容器に対
応させる切換手段を設け、さらに前記2つの供給
手段および前記切換手段を所望時間をおいて作動
制御しうる作動制御手段を付設し、この作動制御
手段の作動によつて自動的に合成反応終了後の各
ヌクレオチド試薬用容器を溶媒、次いで乾燥ガス
によつて洗浄・乾燥可能としたことを特徴とする
DNA等合成装置。
[Scope of Claims] 1. In an apparatus for synthesizing DNA, etc., in which each nucleotide reagent solution is automatically supplied from a large number of nucleotide reagent containers to a reactor according to a predetermined procedure, any one of the large number of nucleotide reagent containers is provided. A means for supplying a solvent for washing and drying the container and a means for supplying a drying gas for discharging the solvent and providing a drying function are attached to the container, and the two supply means are sequentially connected to other nucleotide reagent containers. A switching means corresponding to the above is provided, and an operation control means capable of controlling the operation of the two supply means and the switching means at a desired time is provided, and the synthesis reaction is automatically terminated by the operation of the operation control means. A feature of the present invention is that each subsequent nucleotide reagent container can be washed and dried using a solvent and then a drying gas.
DNA synthesis equipment.
JP19709883A 1983-10-20 1983-10-20 Apparatus for synthesizing dna and the like Granted JPS6089493A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19709883A JPS6089493A (en) 1983-10-20 1983-10-20 Apparatus for synthesizing dna and the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19709883A JPS6089493A (en) 1983-10-20 1983-10-20 Apparatus for synthesizing dna and the like

Publications (2)

Publication Number Publication Date
JPS6089493A JPS6089493A (en) 1985-05-20
JPH0465839B2 true JPH0465839B2 (en) 1992-10-21

Family

ID=16368688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19709883A Granted JPS6089493A (en) 1983-10-20 1983-10-20 Apparatus for synthesizing dna and the like

Country Status (1)

Country Link
JP (1) JPS6089493A (en)

Also Published As

Publication number Publication date
JPS6089493A (en) 1985-05-20

Similar Documents

Publication Publication Date Title
CA1251016A (en) Polynucleotide synthesizing apparatus
JPS60105691A (en) Apparatus for synthesizing polynucleotide
EP0446120B1 (en) Painting system for automobile
JPH05255384A (en) Biopolymer synthesis apparatus and method therefor
KR102619350B1 (en) Universal Jig Unit for MCT Machining
JPH0465839B2 (en)
EP0558050B1 (en) Apparatus and method for isolation of synthetic peptide without loss of reagents
JPH0465840B2 (en)
JPH07284737A (en) Part washing method and apparatus
US6077354A (en) Vehicle painting system having a paint recovery mechanism
JPS59199765A (en) dye purification equipment
CN217041396U (en) Flow path system of full-automatic solid phase extraction instrument
JP5214952B2 (en) Reaction tube cleaning apparatus, automatic analyzer, and detergent channel cleaning method for reaction tube cleaning apparatus
JPS6311360B2 (en)
WO1990007975A1 (en) A method and an apparatus for dissolving a solid substance in a solvent
JP2657705B2 (en) Multi-function transfer tank
CN220642846U (en) Sewage treatment filter tank
JPS60105692A (en) Apparatus for synthesizing polynucleotide
JPS6118013Y2 (en)
JP7483116B1 (en) Painting Equipment
JPS6118015Y2 (en)
Jagadeeswaran et al. Use of reverse-phase chromatography in the Maxam-Gilbert method of DNA sequencing A step toward automation
JPH0634687Y2 (en) Chemical analyzer
JPS58148897A (en) Automated dna microsynthesizer
JPS6197297A (en) polynucleotide synthesizer